Drug release from PLGA-based microparticles: Effects of the "microparticle:bulk fluid" ratio

International Journal of Pharmaceutics

Volumn 383, Issue 1-2, 2010, Pages 123-131

  Klose, D ^a,b   Siepmann, F ^a   Willart, J F ^a   Descamps, M ^a   Siepmann, J ^a  

^a UNIV LILLE   (France)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Controlled release; In vitro release; Microparticle; PLGA; Release conditions

Indexed keywords

BUFFER; IBUPROFEN; LIDOCAINE; PHOSPHATE; POLYGLACTIN; PROPRANOLOL;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; GLASS TRANSITION TEMPERATURE; IN VITRO STUDY; MICROSCOPY; PARTICLE SIZE; PH; POROSITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

BUFFERS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; IBUPROFEN; LACTIC ACID; LIDOCAINE; MEMBRANE FLUIDITY; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; PROPRANOLOL;

EID: 70449710805     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.09.012     Document Type: Article

References (35)

1. Anderson J.M., and Shive M.S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Del. Rev. 28 (1997) 5-24
2. Aubert-Pouëssel A., Bibby D.C., Venier-Julienne M.C., Hindre F., and Benoit J.P. A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres. Pharm. Res. 19 (2002) 1046-1051
3. Bain D.F., Munday D.L., and Smith A. Modulation of rifampicin release from spray-dried microspheres using combinations of poly-(d,l-lactide). J. Microencapsul. 16 (1999) 369-385
4. Berkland C., Kim K., and Pack D.W. PLG microsphere size controls drug release rate through several competing factors. Pharm. Res. 20 (2003) 1055-1062
5. Blasi P., D'Souza S.S., Selmin F., and DeLuca P.P. Plasticizing effect of water on poly(lactide-co-glycolide). J. Control. Rel. 108 (2005) 1-9
6. Bodmeier R., and Chen H. Evaluation of biodegradable poly(lactide) pellets prepared by direct compression. J. Pharm. Sci. 78 (1989) 819-822
7. Brunner A., Maeder K., and Goepferich A. pH and osmotic pressure inside biodegradable microspheres during erosion. Pharm. Res. 16 (1999) 847-853
8. Burgess D.J., Hussain A.S., Ingallinera T.S., and Chen M.L. Assuring quality and performance of sustained and controlled release parenterals: AAPS workshop report, co-sponsored by FDA and USP. Pharm. Res. 19 (2002) 1761-1768
9. Burgess D.J., Crommelin D.J.A., Hussain A.S., and Chen M.L. Assuring quality and performance of sustained and controlled release parenterals. Eur. J. Pharm. Sci. 21 (2004) 679-690
10. Conti C.B., Genta I., Giunchedi P., and Modena T. Testing of "in vitro" dissolution behaviour of microparticulate drug delivery systems. Drug Dev. Ind. Pharm. 21 (1995) 1223-1233
11. In: Crank J. (Ed). The Mathematics of Diffusion. 2nd ed. (1975), Clarendon Press, Oxford
12. D'Souza, S.S., DeLuca, P.P., 2005a. Development of a dialysis in vitro release method for biodegradable microspheres. AAPS PharmSciTech. 6, article 42.
13. D'Souza, S.S., Faraj, J.A., DeLuca, P.P., 2005b. A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres. AAPS PharmSciTech. 6, article 70.
14. D'Souza S.S., and DeLuca P.P. Methods to assess in vitro drug release from injectable polymeric particulate systems. Pharm. Res. 23 (2006) 460-474
15. Faisant N., Siepmann J., and Benoit J.P. PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release. Eur. J. Pharm. Sci. 15 (2002) 355-366
16. Faisant N., Akiki J., Siepmann F., Benoit J.P., and Siepmann J. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory. Int. J. Pharm. 314 (2006) 189-197
17. Fournier E., Passirani C., Montero-Menei C.N., and Benoit J.P. Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility. Biomaterials 24 (2003) 3311-3331
18. Giteau A., Venier-Julienne M.C., Aubert-Pouëssel A., and Benoit J.P. How to achieve sustained and complete protein release from PLGA-based microparticles?. Eur. J. Pharm. Biopharm. 350 (2008) 14-26
19. Grizzi I., Garreau S.L., and Vert M. Hydrolytic degradation of devices based on poly(dl-lactic acid) size-dependence. Biomaterials 16 (1995) 305-311
20. Guse C., Koennings S., Blunk T., Siepmann J., and Goepferich A. Programmable implants - from pulsatile to controlled release. Int. J. Pharm. 314 (2006) 161-169
21. Ignatius A.A., and Cleas L.E. In vitro biocompatibility of bioresorbable polymers: poly(l,dl-lactide) and poly(l-lactide-co-glycolide). Biomaterials 17 (1996) 831-839
22. Kang J., and Schwendeman S.P. Pore closing and opening in biodegradable polymers and their effect on the controlled release of proteins. Mol. Pharm. 4 (2007) 104-118
23. Klose D., Siepmann F., Elkharraz K., Krenzlin S., and Siepmann J. How porosity and size affect the drug release mechanisms from PLGA-based microparticles. Int. J. Pharm. 314 (2006) 198-206
24. Klose D., Siepmann F., Elkharraz K., and Siepmann J. PLGA-based drug delivery systems: importance of the type of drug and device geometry. Int. J. Pharm. 354 (2008) 95-103
25. Lu L., Garcia C.A., and Mikos A.G. In vitro degradation of thin poly(dl-lactic-co-glycolic acid) films. J. Biomed. Mater. Res. 46 (1999) 236-244
26. Menei P., Daniel V., Montero-Menei C., Brouillard M., Pouplard-Barthelaix A., and Benoit J.P. Biodegradation and brain tissue reaction to poly(d,l-lactide-co-glycolide) microspheres. Biomaterials 14 (1993) 470-478
27. Menei P., Jadaud E., Faisant N., Boisdron-Celle M., Michalak S., Fournier D., Delhaye M., and Benoit J.P. Stereotaxic implantation of 5-Fluorouracil-releasing microspheres in malignant glioma. Cancer 100 (2004) 405-410
28. Ravivarapu H.B., Burton K., and DeLuca P.P. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. Eur. J. Pharm. Biopharm. 50 (2000) 263-270
29. Ravivarapu H.B., Lee H., and DeLuca P.P. Enhancing initial release of peptide from poly(lactic-co-glycolic acid) (PLGA) microspheres by addition of porosigen and increasing drug load. Pharm. Dev. Technol. 5 (2000) 287-296
30. Shameem, M., Lee, H., DeLuca, P.P., 1999. A short term (accelerated release) approach to evaluate peptide release from PLGA depot-formulations. AAPS Pharmsci. 1, article 7.
31. Siepmann J., and Goepferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv. Drug Del. Rev. 48 (2001) 229-247
32. Siepmann J., Faisant N., and Benoit J.P. A new mathematical model quantifying drug release from bioerodible microparticles using Monte Carlo simulations. Pharm. Res. 19 (2002) 1887-1895
33. Siepmann J., Elkharraz K., Siepmann F., and Klose D. How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment. Biomacromolecules 6 (2005) 2312-2319
34. Siepmann J., Siepmann F., and Florence A.T. Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms. Int. J. Pharm. 314 (2006) 101-119
35. Siepmann J., and Siepmann F. Mathematical modeling of drug delivery. Int. J. Pharm. 364 (2008) 328-343